Distinguished Research Professor, Department of Integrative Biology and Physiology, University of California, Los Angeles
Distinguished Research Professor, Department of Integrative Biology and Physiology, University of California, Los Angeles
Professor of Community Medicine and Public Health, University of Connecticut School of Medicine
President and Professor, Olin College of Engineering
Lead Venture Investor, Portfolia FemTech Fund I & II
Chief Policy Officer, Endocrine Society
Editor-in-Chief, Proceedings of the National Academies of Science
Senior Sociologist, RAND Corporation
CEO and Founder, Dot Laboratories, Inc. (DotLab)
Head of Clinical Policy and Strategy for Verily and Google Health, Adjunct Professor, Duke University and Stanford University, Former FDA Deputy Commissioner to Barack Obama
President, University of Washington
NIH Associate Director for Research on Women's Health and Director, NIH Office of Research on Women's Health
Director, National Institutes of Health (NIH)
Environmental, Social and Governance Analyst, Bloomberg Intelligence
Executive Director, Patient-Centered Outcomes Research Institute (PCORI)
Deputy Assistant Director, Directorate for Social, Behavioral, Economic Sciences (SBE), National Science Foundation
U.S. House of Representatives, Pennsylvania's 4th district
Founder and CEO, Demy-Colton
CEO, All of Us Research Program, National Institutes of Health (NIH)
Vice President, Research Intelligence, Elsevier
Director, National Institute of Allergy and Infectious Diseases (NIAD), National Institutes of Health (NIH)
President and Executive Director, Foundation for the National Institutes of Health (FNIH)
Managing Partner, Lifesciences and Healthcare Practice, Silicon Valley Bank
Deputy Director, Maternal, Newborn, and Child Health - Discovery & Tools, Global Health, Bill & Melinda Gates Foundation
Host, BioTech Nation (NPR), Professor, Bioentrepreneurship, University of San Francisco
Professor of Law, University of Maryland, Carey School of Law Core Faculty, Johns Hopkins Berman Institute of Bioethics
Chief Diversity, Equity and Inclusion Officer, the Alzheimer's Association
Founder and Managing Director, EXXclaim Capital; Co-founder Evolvence India Life Science Fund
President, Wellesley College
Vice President of Global Development and Therapeutic Area Head of Hematology, Amgen
National Vice President, Women's and Kids Health Initiatives, Consumer Health, American Heart Association
Deputy Director for Extramural Research, National Institutes of Health (NIH)
Chief Life Sciences Editor, Nature Communications
CEO and Founder, WHAM, TheWHAMreport.org
Assistant Secretary for Health, HHS Office of the Secretary
Vice President of Strategy and Communications, Research! America
Managing Director, Science Futures LLC
Associate Dean for Research at the College of Medicine, Howard University
National Medical Association 121st President, Chief Diversity Officer, Professor of Family Medicine with Tenure, The Ohio State University Wexner Medical Center, Associate Dean for Diversity
President and CEO, Biotechnology Innovation Organization (BIO)
Senior Publisher, Cell Press/Elsevier
Senior Vice President and Counsel, Cavarocchi - Ruscio - Dennis Associates, LLC
Deputy Director for Science and Society for the White House Office of Science and Technology Policy
Therapeutic Area Lead, U.S. Medical Affairs, Women's Health, AbbVie
Chief Executive Officer and Executive Publisher, Science Journals, American Association for the Advancement of Science (AAAS)
Communication Associate, American Association for the Advancement of Science (AAAS) Center for Public Engagement with Science and Technology
Senior Scientist Emerita, Fogarty International Center, National Institutes of Health (NIH)
President and CEO, National Hispanic Medical Association
John L. Hinds Professor of History of Science, Stanford University
President and CEO, Society for Women's Health Research
Vice President, Mary Ann Liebert Inc., Executive Director, Institute for Professional Education, Executive Director, Rosalind Franklin Society
Senior Client Strategist, NeuroLeadership Institute
Professor of Orthopaedic Surgery (KUMC), University of Kansas Medical Center and Past-President (AMWA), American Medical Women's Association
Deputy Director, Congressionally Directed Medical Research Programs
Co-Founder, Equity Quotient
Associate Commissioner for Women's Health, Director, Office of Women's Health (OWH), Office of the Commissioner, US Food and Drug Administration (FDA)
Vice President US Medical Affairs - Women's Healthcare, Bayer Women's HealthCare
President, American Medical Women's Association, Clinical Associate Professor Emerita of OBGyn, Western Michigan University Homer Stryker School of Medicine
Health Science Strategy and Relations Lead, NIH Office of Research on Women's Health
Research Professor, Department of Health Policy and Management, Milken Institute, George Washington University, Advisory Committee on Research on Women's Health (ACRWH)
VA Greater Los Angeles Healthcare System, Director, VA HSR&D Center for the Study of Healthcare Innovation, Implementation and Policy, Director, VA Women's Health Research Network
Associate Professor, Sol Price School of Public Policy, Senior Fellow, Schaeffer Center for Health Policy and Economics, University of Southern California
5th Annual Vivian Pinn Symposium:
Integrating Sex and Gender into Biomedical Research as a Path for Better Science and Innovation
The Office of Research on Women’s Health (ORWH) is thrilled to host the 5th Annual Vivian Pinn Symposium in partnership with the Foundation for the National Institutes of Health (FNIH). In line with ORWH’s mission of putting science to work for the health of women, this event serves as a forum for experts across sectors to communicate and collaborate for the advancement of women’s health.
This year’s event will focus on illustrating the scientific, societal, and economic opportunities of integrating sex and gender into biomedical research and the power of working together. Sex-and gender-aware research is critical for rigorous science, maximizing returns on research investment, and advancing women’s health. However, despite progress made, consideration of sex and gender influences is inconsistently applied across the biomedical ecosystem, highlighting a need for greater integration.
This event will feature a series of panels and breakout sessions with experts from across diverse sectors of academia, industry, non-profits, private funding, and government to generate discussion of system-wide solutions—driving progress towards a healthier future for everyone.
Symposium Goals:
1) Create bridges and capacity to work bi-directionally across silos within the scientific enterprise to build a resilient, interconnected network that includes federal and private funders of research, industry and business, journal editors and publishers, professional societies, scientific and health organizations, healthcare providers, researchers, academic institutions, policymakers, and the public.
2) Develop strategies to achieve the integration of sex and gender considerations throughout the biomedical research enterprise.
3) Characterize issues related to the health of women and explore women’s health research, along with public health opportunities from a multidimensional perspective to advance the integration of sex and gender considerations via trans-sector approaches and partnerships.